ArticleLeukemia2023

Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma.

Anuvrat Sircar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.